Medicare, Medicaid, TRICARE & VA GLP-1 Coverage
Almost everything written about paying for GLP-1s assumes you have commercial insurance or none at all. If you are on Medicare, Medicaid, TRICARE or VA care, the rules are completely different — and one of them changed for the better this year.
The headline: Medicare now covers GLP-1s
As of July 1, 2026, Medicare.gov states that Medicare covers Foundayo® (tablet), Wegovy® (injection or tablet) and Zepbound® (KwikPen only). Through the Medicare GLP-1 Bridge demonstration, Foundayo and Wegovy are $50 per month for eligible beneficiaries.
If you are on Medicare and have been paying cash — or have been told Medicare does not cover weight-loss drugs, which was true until recently — this is worth acting on. $50 a month beats every cash-pay program on this site.
Program by program
Medicare
Covers as of July 1, 2026- What is covered
- Medicare.gov states that starting July 1, 2026, Medicare covers Foundayo® (tablet), Wegovy® (injection or tablet) and Zepbound® (KwikPen only). This is a substantial change — Medicare previously did not cover medication prescribed solely for weight loss.
- What you pay
- Through the Medicare GLP-1 Bridge demonstration, Foundayo (tablet) and Wegovy (injection or tablet) are $50 per month for eligible beneficiaries. Medicare publishes a dedicated leaflet on this, "GLP-1 Drugs for $50 a Month".
- The catch
- Not every product is included — note that Zepbound is covered as the KwikPen only. Check the current medicare.gov page for your specific drug and formulation before assuming coverage.
Medicaid
Varies by state — 13 states- What is covered
- KFF reports that 13 state Medicaid programs covered GLP-1s for obesity treatment under fee-for-service as of January 2026. Coverage for obesity is optional for states; coverage for diabetes, cardiovascular disease and sleep apnea indications is required.
- What you pay
- Where covered, standard Medicaid cost-sharing applies, which is typically minimal.
- The catch
- The direction of travel is negative. KFF notes four states eliminated obesity coverage after October 2025 — California, New Hampshire, Pennsylvania and South Carolina — and that state interest in expanding coverage is waning, with cost the primary factor. North Carolina eliminated coverage in October 2025 and reinstated it in December 2025.
TRICARE
Covers with criteria- What is covered
- TRICARE covers weight loss medications including GLP-1s when you meet criteria based on diagnosis, medical necessity and your specific plan. Published requirements include a diagnosis of obesity and meeting age and BMI criteria — generally a BMI of 30 or above, or 27 or above with an additional risk factor such as diabetes, sleep apnea or high blood pressure.
- What you pay
- Standard TRICARE pharmacy cost-sharing applies.
- The catch
- Eligibility narrowed. Express Scripts military pharmacy states that as of August 31, 2025, coverage for weight loss medications is no longer available for non-TRICARE Prime and non-TRICARE Select beneficiaries.
VA
Available through VA care- What is covered
- The VA makes FDA-approved weight management medications available for chronic weight management, generally alongside its MOVE! Weight Management Program rather than as a standalone prescription.
- What you pay
- Standard VA pharmacy copay structure applies.
- The catch
- Access runs through VA clinical pathways and availability has varied by facility. Speak to your VA primary care team about MOVE! and medication eligibility rather than expecting a direct prescription route.
Patient assistance: free or near-free medication
These programs are consistently underused, largely because the companies that would tell you about them are the ones selling you an alternative. If you are uninsured or low-income, check these before paying anything.
Novo Nordisk Patient Assistance Program
Provides medicine at no cost to those who qualify, with no registration charge or monthly fee and shipping covered. You must be a US citizen or legal resident with household income at or below the stated federal poverty level threshold — at or below 400% FPL for most medications for uninsured applicants. It is aimed at people with Medicare or no insurance; having commercial insurance generally makes you ineligible, and Medicaid-eligible applicants must submit a denial letter. Novo notes some medicines left the program for 2026, so confirm your specific drug.
Lilly Cares
A nonprofit charitable organization that provides prescribed Lilly medications free for up to 12 months to qualifying US patients. Check the current product list directly, since which medications are included changes.
PAN Foundation obesity copay fund
The PAN Foundation opened its first obesity copay fund providing grants of up to $1,000 to help with copays for obesity medications, including FDA-approved GLP-1s. Charity copay funds typically open and close as money is committed, so check current status rather than assuming availability.
Important eligibility trap
Manufacturer copay cards and manufacturer patient assistance programs are different things with opposite rules. Copay savings cards — including the NovoCare offer that brings Wegovy to as little as $25 a month — generally exclude anyone with Medicare, Medicaid, VA or TRICARE coverage. Patient assistance programs are generally for people who are uninsured or on Medicare. If one route rejects you, check the other.
If none of the above applies to you
Discount cards and cash channels are the fallback, and they have become genuinely competitive:
- GoodRx advertises Wegovy from as low as $149 — against an average retail price it lists at $1,642.83 — and Zepbound from $299. It also runs its own GLP-1 care service.
- SingleCare and Optum Perks publish coupons that reduce brand-name GLP-1 prices, though savings on already- discounted manufacturer channels are usually smaller.
- Mark Cuban Cost Plus Drugs carries generic liraglutide for weight management (the generic of Saxenda) and has partnered with 9amHealth on employer GLP-1 access. Liraglutide is a daily injection and generally less effective than semaglutide or tirzepatide, but the generic makes it materially cheaper.
- Manufacturer-direct remains the simplest cash route — NovoCare Pharmacy from $149/mo and LillyDirect from $299/mo.
The order to check things in
- Your own plan first. Medicare now covers specific GLP-1s; TRICARE covers them with criteria; 13 state Medicaid programs do. Check before assuming you must pay cash.
- The Medicare GLP-1 Bridge if you are on Medicare — $50/month for Foundayo or Wegovy.
- Patient assistance if uninsured or on Medicare without drug coverage — Novo Nordisk PAP and Lilly Cares provide medication free to those who qualify.
- Appeal a denial before giving up. Honest Care sells specialist appeals for $79 with free templates, and Klinic handles prior authorization as part of care.
- Only then compare cash-pay programs. See our cheapest programs ranking.
Frequently asked questions
I was told Medicare does not cover weight loss drugs. Is that still true?
It was true for a long time and is now out of date. Medicare.gov states that starting July 1, 2026 Medicare covers Foundayo (tablet), Wegovy (injection or tablet) and Zepbound (KwikPen only). A lot of advice online — and some pharmacy staff — has not caught up.
Does my state Medicaid cover it?
Only 13 state programs covered GLP-1s for obesity under fee-for-service as of January 2026, and four states dropped coverage after October 2025. Coverage for diabetes, cardiovascular disease and sleep apnea indications is required of all states, so the indication your prescriber documents can matter a great deal.
Can I use a manufacturer savings card with Medicare?
Generally no. Manufacturer copay cards typically exclude government beneficiaries — NovoCare's $25 offer excludes government beneficiaries explicitly. Patient assistance programs work the other way and are often open to Medicare patients without drug coverage.
Do compounded GLP-1 providers take Medicare or Medicaid?
Essentially none of them do — compounded GLP-1 programs are cash-pay by design. Note also that one provider we review, DevotedDoc, states it cannot coordinate coverage for government insurance plans at all. If you have government coverage, the approved-medication route is almost certainly cheaper for you.
Sources
- Medicare.gov — Weight loss drugs coverage
- Medicare.gov — Medicare GLP-1 Bridge: GLP-1 Drugs for $50 a Month
- CMS — Medicare GLP-1 Bridge
- KFF — Medicaid coverage of and spending on GLP-1s
- TRICARE — Coverage of weight loss medications
- Express Scripts military pharmacy — GLP-1 coverage FAQ
- Novo Nordisk Patient Assistance Program
- Lilly Cares
- PAN Foundation — obesity copay fund
- VA — MOVE! Weight Management Program
Where to go next
Disclaimer
This article is general information, not medical, legal or benefits advice. Coverage rules change frequently and vary by plan, state and individual circumstance — everything here reflects what the cited sources published as of August 3, 2026. Verify your own coverage directly with Medicare, your state Medicaid agency, TRICARE or the VA before making decisions. GLP-1 medications are prescription drugs with serious potential risks; discuss treatment with a licensed healthcare professional.
Date reviewed: August 3, 2026